Prosecution Insights
Prosecution Insights
12 pending office actions • 5 clients • 11 examiners • 9 art units • 1 of 12 (8%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (8%) |
| §103 only | 3 (25%) |
| §112 only | 2 (17%) |
| Double-patenting + other | 1 (8%) |
| Multi-statute (no §101) | 5 (42%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KONOPKA, CATHERINE ANNE | 2 | 58.2% | +64.5% |
| BOWMAN, ANDREW J | 1 | 65.7% | +13.1% |
| AFREMOVA, VERA | 1 | 50.7% | +29.2% |
| WARD, AARON DUREL | 1 | — | — |
| NICOL, ALEXANDER W | 1 | 42.9% | +43.1% |
| SINES, BRIAN J | 1 | 80.3% | +4.8% |
| ALLEN, SARAH ELIZABETH | 1 | 60.9% | +45.0% |
| POLIAKOVA-GEORGAN, EKATERINA | 1 | 64.1% | +17.8% |
| KIDWELL, KAITLYN ELIZABETH | 1 | 77.1% | +20.8% |
| EPSTEIN, TODD MATTHEW | 1 | 60.8% | +44.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18520821 | CONTROLLING PRESSURE | SINES, BRIAN J | 55d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18591819 | HOST-BIOME INTERACTIONS | AFREMOVA, VERA | 4d overdue |
| 18027834 | CONTINUOUS INFRARED SPECTROSCOPY SYSTEM AND METHOD | KIDWELL, KAITLYN ELIZABETH | 2d overdue |
| 18566367 | CAS9 NICKASE-MEDIATED GENE EDITING | NICOL, ALEXANDER W | 34d |
| 18577623 | MODULAR PRIME EDITING SYSTEMS FOR GENOME ENGINEERING | WARD, AARON DUREL | — |
| 18553357 | Specific Oligonucleotide-Programmed Readthrough of Nonsense Codons | KONOPKA, CATHERINE ANNE | — |
| 18283201 | PRIME EDITING-BASED SIMULTANEOUS GENOMIC DELETION AND INSERTION | ALLEN, SARAH ELIZABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17921027 | IMPROVED CAS 12A/NLS MEDIATED THERAPEUTIC GENE EDITING PLATFORMS | KONOPKA, CATHERINE ANNE | 16d overdue |
| 18591819 | HOST-BIOME INTERACTIONS | AFREMOVA, VERA | 4d overdue |
| 18027834 | CONTINUOUS INFRARED SPECTROSCOPY SYSTEM AND METHOD | KIDWELL, KAITLYN ELIZABETH | 2d overdue |
| 18566367 | CAS9 NICKASE-MEDIATED GENE EDITING | NICOL, ALEXANDER W | 34d |
| 18810072 | IMPLANTABLE SCAFFOLDS FOR TREATMENT OF SINUSITIS | BOWMAN, ANDREW J | 72d |
| 18553357 | Specific Oligonucleotide-Programmed Readthrough of Nonsense Codons | KONOPKA, CATHERINE ANNE | — |
| 18283201 | PRIME EDITING-BASED SIMULTANEOUS GENOMIC DELETION AND INSERTION | ALLEN, SARAH ELIZABETH | — |
| 18278338 | GENOME EDITING FOR TREATING MUSCULAR DYSTROPHY | POLIAKOVA-GEORGAN, EKATERINA | — |
| Client (Assignee) | Pending OAs |
|---|---|
| UNIVERSITY OF MASSACHUSETTS | 7 |
| EMULATE, Inc. | 2 |
| Lyra Therapeutics | 1 |
| DXCOVER LIMITED | 1 |
| Signablok, Inc. | 1 |
| Art Unit | Apps |
|---|---|
| 1635 | 2 |
| 1637 | 2 |
| 1717 | 1 |
| 1653 | 1 |
| 1634 | 1 |
| 1796 | 1 |
| 2877 | 1 |
| 1652 | 1 |
| 1658 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18810072 | IMPLANTABLE SCAFFOLDS FOR TREATMENT OF SINUSITIS | Lyra Therapeutics, Inc. | BOWMAN, ANDREW J | 1717 | §103 | Non-Final OA | 72d | Pending | Aug 20, 2024 |
| 18591819 | HOST-BIOME INTERACTIONS | Emulate, Inc. | AFREMOVA, VERA | 1653 | §102§112 | Non-Final OA | 4d overdue | Pending | Feb 29, 2024 |
| 18577623 | MODULAR PRIME EDITING SYSTEMS FOR GENOME ENGINEERING | UNIVERSITY OF MASSACHUSETTS | WARD, AARON DUREL | §102§112 | Non-Final OA | — | Pending | Jan 08, 2024 | |
| 18566367 | CAS9 NICKASE-MEDIATED GENE EDITING | UNIVERSITY OF MASSACHUSETTS | NICOL, ALEXANDER W | 1634 | §102§103 | Non-Final OA | 34d | Pending | Dec 01, 2023 |
| 18520821 | CONTROLLING PRESSURE | Emulate, Inc. | SINES, BRIAN J | 1796 | §103 | Non-Final OA | 55d | Pending | Nov 28, 2023 |
| 18553357 | Specific Oligonucleotide-Programmed Readthrough of Nonsense Codons | UNIVERSITY OF MASSACHUSETTS | KONOPKA, CATHERINE ANNE | 1635 | §101§102§112 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18283201 | PRIME EDITING-BASED SIMULTANEOUS GENOMIC DELETION AND INSERTION | UNIVERSITY OF MASSACHUSETTS | ALLEN, SARAH ELIZABETH | 1637 | §103§112 | Non-Final OA | — | Pending | Sep 20, 2023 |
| 18278338 | GENOME EDITING FOR TREATING MUSCULAR DYSTROPHY | UNIVERSITY OF MASSACHUSETTS | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §102§103§112DP | Non-Final OA | — | Pending | Aug 22, 2023 |
| 18027834 | CONTINUOUS INFRARED SPECTROSCOPY SYSTEM AND METHOD | Dxcover Limited | KIDWELL, KAITLYN ELIZABETH | 2877 | §102§103§112 | Final Rejection | 2d overdue | Pending | Mar 22, 2023 |
| 17921027 | IMPROVED CAS 12A/NLS MEDIATED THERAPEUTIC GENE EDITING PLATFORMS | UNIVERSITY OF MASSACHUSETTS | KONOPKA, CATHERINE ANNE | 1635 | §103 | Non-Final OA | 16d overdue | Pending | Oct 24, 2022 |
| 17796184 | A CAS9-PDBD BASE EDITOR PLATFORM WITH IMPROVED TARGETING RANGE AND SPECIFICITY | UNIVERSITY OF MASSACHUSETTS | EPSTEIN, TODD MATTHEW | 1652 | §112 | Non-Final OA | — | Pending | Jul 28, 2022 |
| 16719103 | Inhibition Of TCR Signaling With Peptide Variants | Signablok, Inc. | LEE, JIA-HAI | 1658 | §112 | Non-Final OA | — | AI Ready | Dec 18, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial